SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10QSB - Optional form for quarterly and transition reports of small business issuers:
SEC Accession No. 0000950137-03-004369
Filing Date
2003-08-14
Accepted
2003-08-14 16:12:55
Documents
7
Period of Report
2003-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT c78859sbe10qsb.txt 10QSB 42498
3 EXHIBIT 3.1 c78859sbexv3w1.txt EX-3.1 65571
4 CERTIFICATION OF CEO c78859sbexv31w1.txt EX-31.1 2933
5 CERTIFICATION c78859sbexv31w2.txt EX-31.2 2985
6 CERTIFICATION OF CEO c78859sbexv32w1.txt EX-32.1 1143
7 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER c78859sbexv32w2.txt EX-32.2 1159
8 RISK FACTORS c78859sbexv99w1.txt EX-99.1 28430
  Complete submission text file 0000950137-03-004369.txt   147169
Mailing Address 28101 N. BALLARD DR. SUITE F LAKE FOREST IL 60045
Business Address 28101 N. BALLARD DR. SUITE F LAKE FOREST IL 60045 847-573-8990
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10QSB | Act: 34 | File No.: 000-16929 | Film No.: 03847893
SIC: 2834 Pharmaceutical Preparations